Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New lupus drug shows promise in major trial

NCT ID NCT06617325

Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 04, 2026 · Updated 7 times

Summary

This study tests an experimental drug called dapirolizumab pegol for people with moderate to severe lupus. About 450 participants will receive either the drug or a placebo, added to their usual treatments. The goal is to see if the drug can improve lupus symptoms over 48 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dapirolizumab pegol
What this could lead to
If successful, this could provide a new add-on treatment option to better control lupus symptoms and reduce disease flares.
What could go wrong
This is a Phase 3 trial, but results are not guaranteed. The drug may not work better than placebo, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 450 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Study participant must be ≥16 years of age, (≥18 years of age for China), unless restricted by local regulation, at the time of signing the Informed Consent form (ICF) * Study participants who have moderate to severe disease activity due to either persisting active systemic lupus erythematosus (SLE) or due to an acute worsening of SLE in the scope of frequent relapsing-remitting SLE despite stable standard of care(SOC) medication defined as: a. Diagnosed with SLE at least 24 weeks before the Screening Visit by a qualified physician b. Classified by 2019 SLE European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for SLE c. With serological evidence for SLE at Screening as demonstrated by at least 1 of the following: i) Evidence for anti-dsDNA (defined as evidence for anti-dsDNA antibodies in central laboratory) ii) Either complement C3 \<lower limit of normal (LLN) OR complement C4 \<LLN as measured by central laboratory iii) Antinuclear antibodies with a titer of at least 1:80 confirmed by central laboratory in combination with evidence of at least 1 of the following SLE typical autoantibodies: 1. Anti-Smith (anti-Sm) antibodies (central laboratory or source verifiable history) 2. Anti-Sjögren's syndrome antibody A (Anti-SSA) (Ro)/Anti-Sjögren's syndrome antibody B (anti-SSB) (La) autoantibodies (central laboratory) 3. Historical evidence for anti-dsDNA antibodies 4. Anti-ribonucleoprotein (RNP) autoantibodies (central laboratory) d. Moderately to severely active defined as: * British Isles Lupus Assessment Group Disease Activity Index 2004 (BILAG 2004) Grade B in ≥2 organ systems and/or a BILAG 2004 Grade A in ≥1 organ systems at Screening and Baseline Visit AND * Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) ≥6 at the Screening Visit AND * SLEDAI-2K without labs ≥4 at Baseline Visit e. Receiving the following standard of care (SOC) medications at stable dose: * Antimalarial treatment in combination with glucocorticoids and/or immunosuppressants or as stand-alone treatment if justified OR * Treatment with glucocorticoids and/or immunosuppressants if antimalarial treatment is not appropriate (ie, there is documented intolerance in medical history, documented lack of efficacy, contraindications, or lack of availability) Exclusion Criteria: * Study participant has any medical or psychiatric condition (including conditions due to neuropsychiatric SLE) that, in the opinion of the Investigator, could jeopardize or would compromise the study participant's ability to participate in this study. This includes study participants with a life-threatening condition * Study participant has a history of an anaphylactic reaction to parenteral administration of contrast agents, human or murine proteins, or monoclonal antibodies. This includes systemic reactions due to latex allergy * Study participant has a history of malignancy, except the following treated cancers: cervical carcinoma in situ (after complete resection \[eg, curettage, electrodesiccation\] not later than 4 weeks prior to the Screening Visit \[V1\]), basal cell carcinoma, or dermatological squamous cell carcinoma * Study participant has a mixed connective tissue disease, scleroderma, and/or overlap syndrome of these diseases with SLE * Study participant has evidence of human immunodeficiency virus (HIV) infection, agammaglobulinemias, T-cell deficiencies, or human T-cell lymphotropic virus-1 infection at any time prior to or during the study * Study participant has clinically significant active or latent infection * Study participant had a reactivated latent infection (eg, cytomegalovirus, herpes simplex virus, or herpes zoster infection) or opportunistic infection (including but not limited to, pneumocystis, cytomegalovirus, or severe herpes zoster infection) within 12 weeks prior to the first study medication infusion (Visit 2) or is currently receiving suppressive therapy for an opportunistic infection * Study participants who have received live/live attenuated vaccines within 6 weeks prior to the first study medication infusion * Study participant has used the prohibited medications within the time frame (Wash-Out Period) listed in the Protocol * Study participant has previously been randomized within this study or has previously been assigned to treatment with dapirolizumab pegol (DZP) in a study evaluating DZP * Study participant has participated in another study of an investigational medicinal product (IMP) within the previous 12 weeks or 5 half-lives of the IMP whatever is longer, or is currently participating in another study of an IMP * Study participant has chronic kidney failure stage 4, manifested by estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m2, or serum creatinine \>2.5 mg/dL, or participant has proteinuria \>3g/day, or protein:creatinine ratio \>340 mg/mmol at the Screening Visit

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Systemic lupus erythematosus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Systemic lupus erythematosus

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    237 sites in 23 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sl0044 20019

    RECRUITING

    Guangzhou, China

  • Sl0044 20020

    RECRUITING

    Shanghai, China

  • Sl0044 20024

    RECRUITING

    Nanjing, China

  • Sl0044 20025

    RECRUITING

    Wenzhou, China

  • Sl0044 20030

    RECRUITING

    Chūōku, Japan

  • Sl0044 20031

    RECRUITING

    Sapporo, Japan

  • Sl0044 20032

    RECRUITING

    Suita-shi, Japan

  • Sl0044 20035

    RECRUITING

    Bunkyō City, Japan

  • Sl0044 20039

    RECRUITING

    Kawagoe, Japan

  • Sl0044 20042

    RECRUITING

    Sasebo, Japan

  • Sl0044 20045

    RECRUITING

    Kita-gun, Japan

  • Sl0044 20065

    RECRUITING

    Kitakyushu, Japan

  • Sl0044 20069

    RECRUITING

    Meguro-ku, Japan

  • Sl0044 20070

    RECRUITING

    Shinjuku-ku, Japan

  • Sl0044 20071

    RECRUITING

    Nagasaki, Japan

  • Sl0044 20076

    RECRUITING

    Shinjuku-ku, Japan

  • Sl0044 20080

    RECRUITING

    Taichung, Taiwan

  • Sl0044 20082

    RECRUITING

    Taiyuan, Taiwan

  • Sl0044 20084

    RECRUITING

    Saga, Japan

  • Sl0044 20086

    RECRUITING

    Taipei, Taiwan

  • Sl0044 20092

    RECRUITING

    Suwon, South Korea

  • Sl0044 20099

    RECRUITING

    Taipei, Taiwan

  • Sl0044 20104

    RECRUITING

    Seoul, South Korea

  • Sl0044 20105

    RECRUITING

    Seoul, South Korea

  • Sl0044 20108

    RECRUITING

    Incheon, South Korea

  • Sl0044 20113

    RECRUITING

    Taichung, Taiwan

  • Sl0044 20128

    RECRUITING

    Beijing, China

  • Sl0044 20132

    ACTIVE_NOT_RECRUITING

    Zhengzhou, China

  • Sl0044 20136

    RECRUITING

    Tianjin, China

  • Sl0044 20137

    RECRUITING

    Chengdu, China

  • Sl0044 20141

    RECRUITING

    Busan, South Korea

  • Sl0044 20142

    RECRUITING

    Taichung, Taiwan

  • Sl0044 20157

    RECRUITING

    Beijing, China

  • Sl0044 20171

    RECRUITING

    Sendai, Japan

  • Sl0044 20172

    RECRUITING

    Shanghai, China

  • Sl0044 20173

    RECRUITING

    Beijing, China

  • Sl0044 20180

    RECRUITING

    Wuhan, China

  • Sl0044 20185

    RECRUITING

    Jinan, China

  • Sl0044 20186

    RECRUITING

    Changzhou, China

  • Sl0044 20192

    RECRUITING

    Nanchang, China

  • Sl0044 20196

    RECRUITING

    Bunkyō City, Japan

  • Sl0044 20201

    RECRUITING

    Bengbu, China

  • Sl0044 20204

    RECRUITING

    Suzhou, China

  • Sl0044 20270

    RECRUITING

    Wuhan, China

  • Sl0044 20271

    RECRUITING

    Haikou, China

  • Sl0044 20272

    RECRUITING

    Pingxiang, China

  • Sl0044 20273

    RECRUITING

    Yangzhou, China

  • Sl0044 20274

    RECRUITING

    Xi'an, China

  • Sl0044 20275

    RECRUITING

    Urumuqi, China

  • Sl0044 20276

    RECRUITING

    Yoshida-gun, Japan

  • Sl0044 20277

    RECRUITING

    Suita, Japan

  • Sl0044 20278

    RECRUITING

    Tsu, Japan

  • Sl0044 20279

    RECRUITING

    Bunkyō City, Japan

  • Sl0044 20281

    RECRUITING

    Fukuoka, Japan

  • Sl0044 20283

    RECRUITING

    Sagamihara, Japan

  • Sl0044 20285

    RECRUITING

    Shinjuku-ku, Japan

  • Sl0044 20287

    RECRUITING

    Nagoya, Japan

  • Sl0044 20288

    RECRUITING

    Shinjuku-ku, Japan

  • Sl0044 20290

    RECRUITING

    Guilin, China

  • Sl0044 20291

    RECRUITING

    Changchun, China

  • Sl0044 20293

    RECRUITING

    Baotou, China

  • Sl0044 20295

    RECRUITING

    Changsha, China

  • Sl0044 20296

    RECRUITING

    Hangzhou, China

  • Sl0044 20301

    ACTIVE_NOT_RECRUITING

    Kurashiki, Japan

  • Sl0044 20330

    RECRUITING

    New Taipei City, Taiwan

  • Sl0044 20331

    RECRUITING

    Nanning, China

  • Sl0044 20341

    RECRUITING

    Xiamen, China

  • Sl0044 20342

    RECRUITING

    Changchun, China

  • Sl0044 20346

    RECRUITING

    Shantou, China

  • Sl0044 20351

    RECRUITING

    Seoul, South Korea

  • Sl0044 20358

    RECRUITING

    Wakayama, Japan

  • Sl0044 20360

    RECRUITING

    Guangzhou, China

  • Sl0044 20361

    RECRUITING

    Zhuzhou, China

  • Sl0044 20362

    RECRUITING

    Taipei, Taiwan

  • Sl0044 20363

    RECRUITING

    Shijiazhuang, China

  • Sl0044 20364

    RECRUITING

    Jiujiang, China

  • Sl0044 20365

    RECRUITING

    Kawasaki-shi, Japan

  • Sl0044 20368

    RECRUITING

    Osaka, Japan

  • Sl0044 20369

    RECRUITING

    Kyoto, Japan

  • Sl0044 20370

    RECRUITING

    Yokohama, Japan

  • Sl0044 20371

    RECRUITING

    Toyoake-shi, Japan

  • Sl0044 40002

    RECRUITING

    Leuven, Belgium

  • Sl0044 40027

    RECRUITING

    Herne, Germany

  • Sl0044 40037

    RECRUITING

    Lublin, Poland

  • Sl0044 40044

    RECRUITING

    Poznan, Poland

  • Sl0044 40045

    RECRUITING

    A Coruña, Spain

  • Sl0044 40049

    RECRUITING

    Seville, Spain

  • Sl0044 40060

    RECRUITING

    Liège, Belgium

  • Sl0044 40072

    RECRUITING

    Freiburg im Breisgau, Germany

  • Sl0044 40078

    RECRUITING

    Leipzig, Germany

  • Sl0044 40097

    RECRUITING

    Warsaw, Poland

  • Sl0044 40098

    RECRUITING

    Warsaw, Poland

  • Sl0044 40101

    RECRUITING

    Sabadell, Spain

  • Sl0044 40103

    RECRUITING

    Seville, Spain

  • Sl0044 40106

    RECRUITING

    Seville, Spain

  • Sl0044 40113

    RECRUITING

    London, United Kingdom

  • Sl0044 40139

    RECRUITING

    Jena, Germany

  • Sl0044 40148

    RECRUITING

    Roma, Italy

  • Sl0044 40159

    RECRUITING

    Barcelona, Spain

  • Sl0044 40160

    RECRUITING

    Barcelona, Spain

  • Sl0044 40176

    RECRUITING

    Pisa, Italy

  • Sl0044 40281

    RECRUITING

    Leeds, United Kingdom

  • Sl0044 40291

    RECRUITING

    Milan, Italy

  • Sl0044 40292

    RECRUITING

    Groningen, Netherlands

  • Sl0044 40322

    WITHDRAWN

    Dessau, Germany

  • Sl0044 40341

    RECRUITING

    Málaga, Spain

  • Sl0044 40356

    RECRUITING

    Dresden, Germany

  • Sl0044 40376

    RECRUITING

    Athens, Greece

  • Sl0044 40377

    RECRUITING

    Heraklion, Greece

  • Sl0044 40386

    RECRUITING

    Cologne, Germany

  • Sl0044 40392

    RECRUITING

    Novi Sad, Serbia

  • Sl0044 40397

    RECRUITING

    Wroclaw, Poland

  • Sl0044 40398

    RECRUITING

    Katowice, Poland

  • Sl0044 40402

    RECRUITING

    Tübingen, Germany

  • Sl0044 40466

    RECRUITING

    Kragujevac, Serbia

  • Sl0044 40471

    RECRUITING

    Milan, Italy

  • Sl0044 40480

    RECRUITING

    Berlin, Germany

  • Sl0044 40481

    RECRUITING

    Wroclaw, Poland

  • Sl0044 40484

    RECRUITING

    Poznan, Poland

  • Sl0044 40489

    RECRUITING

    Odense, Denmark

  • Sl0044 40501

    RECRUITING

    Athens, Greece

  • Sl0044 40502

    RECRUITING

    Krakow, Poland

  • Sl0044 40506

    RECRUITING

    Montpellier, France

  • Sl0044 40507

    RECRUITING

    Larissa, Greece

  • Sl0044 40509

    RECRUITING

    Padova, Italy

  • Sl0044 40513

    RECRUITING

    Copenhagen, Denmark

  • Sl0044 40514

    RECRUITING

    Genova, Italy

  • Sl0044 40521

    RECRUITING

    Mérida, Spain

  • Sl0044 40562

    RECRUITING

    Aarhus, Denmark

  • Sl0044 40565

    RECRUITING

    Maastricht, Netherlands

  • Sl0044 40617

    RECRUITING

    Santander, Spain

  • Sl0044 40675

    RECRUITING

    Roma, Italy

  • Sl0044 40701

    RECRUITING

    Sheffield, United Kingdom

  • Sl0044 40715

    RECRUITING

    Vogelsang-gommern, Germany

  • Sl0044 40716

    RECRUITING

    Cologne, Germany

  • Sl0044 40717

    RECRUITING

    Greifswald, Germany

  • Sl0044 40725

    RECRUITING

    West Bromwich, United Kingdom

  • Sl0044 40730

    RECRUITING

    Belgrade, Serbia

  • Sl0044 40795

    RECRUITING

    Katowice, Poland

  • Sl0044 40815

    RECRUITING

    München, Germany

  • Sl0044 40816

    RECRUITING

    Brescia, Italy

  • Sl0044 40821

    RECRUITING

    Poznan, Poland

  • Sl0044 40826

    RECRUITING

    Badajoz, Spain

  • Sl0044 40830

    RECRUITING

    Rozzano, Italy

  • Sl0044 40838

    RECRUITING

    Amsterdam, Netherlands

  • Sl0044 40839

    RECRUITING

    Castellon, Spain

  • Sl0044 40847

    RECRUITING

    Bath, United Kingdom

  • Sl0044 40848

    RECRUITING

    Le Mans, France

  • Sl0044 40853

    RECRUITING

    Santiago de Compostela, Spain

  • Sl0044 40854

    RECRUITING

    Mainz, Germany

  • Sl0044 40857

    RECRUITING

    Madrid, Spain

  • Sl0044 40858

    RECRUITING

    Belfast, United Kingdom

  • Sl0044 40860

    RECRUITING

    Roma, Italy

  • Sl0044 40861

    RECRUITING

    Niška Banja, Serbia

  • Sl0044 40863

    RECRUITING

    Vitoria-Gasteiz, Spain

  • Sl0044 40864

    RECRUITING

    Newcastle upon Tyne, United Kingdom

  • Sl0044 40896

    RECRUITING

    Bordeaux, France

  • Sl0044 40897

    RECRUITING

    Roma, Italy

  • Sl0044 40903

    RECRUITING

    Aalborg, Denmark

  • Sl0044 40908

    RECRUITING

    Dubai, United Arab Emirates

  • Sl0044 50001

    RECRUITING

    Jackson, Tennessee, 38305, United States

  • Sl0044 50010

    RECRUITING

    Brooklyn, New York, 11201, United States

  • Sl0044 50023

    RECRUITING

    Baton Rouge, Louisiana, 70836, United States

  • Sl0044 50036

    RECRUITING

    Mesquite, Texas, 75150, United States

  • Sl0044 50045

    RECRUITING

    Toronto, Canada

  • Sl0044 50052

    RECRUITING

    Phoenix, Arizona, 85032, United States

  • Sl0044 50058

    RECRUITING

    Avondale, Arizona, 85392, United States

  • Sl0044 50061

    RECRUITING

    Spokane Valley, Washington, 99216, United States

  • Sl0044 50074

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • Sl0044 50077

    RECRUITING

    New York, New York, 10021, United States

  • Sl0044 50219

    RECRUITING

    Detroit, Michigan, 48201, United States

  • Sl0044 50238

    RECRUITING

    Charlotte, North Carolina, 28211, United States

  • Sl0044 50239

    RECRUITING

    Brandon, Florida, 33511, United States

  • Sl0044 50241

    RECRUITING

    Syracuse, New York, 13210, United States

  • Sl0044 50250

    RECRUITING

    Cuernavaca, Mexico

  • Sl0044 50257

    RECRUITING

    La Jolla, California, 92037, United States

  • Sl0044 50258

    RECRUITING

    Los Angeles, California, 90022, United States

  • Sl0044 50259

    RECRUITING

    Rimouski, Canada

  • Sl0044 50264

    RECRUITING

    Manhasset, New York, 11030, United States

  • Sl0044 50275

    RECRUITING

    La Palma, California, 90623-1730, United States

  • Sl0044 50285

    RECRUITING

    Lake Charles, Louisiana, 70605, United States

  • Sl0044 50316

    RECRUITING

    San Leandro, California, 94578, United States

  • Sl0044 50319

    RECRUITING

    Iowa City, Iowa, 52242., United States

  • Sl0044 50324

    RECRUITING

    Plantation, Florida, 33324, United States

  • Sl0044 50340

    RECRUITING

    Orange, California, 92868, United States

  • Sl0044 50362

    RECRUITING

    Gainesville, Florida, 32610, United States

  • Sl0044 50365

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • Sl0044 50550

    RECRUITING

    Chandler, Arizona, 85225, United States

  • Sl0044 50562

    RECRUITING

    Frisco, Texas, 75035, United States

  • Sl0044 50566

    RECRUITING

    Gainesville, Georgia, 30501-2418, United States

  • Sl0044 50585

    RECRUITING

    Winter Park, Florida, 32789, United States

  • Sl0044 50586

    RECRUITING

    Louisville, Kentucky, 40202-5700, United States

  • Sl0044 50630

    RECRUITING

    Clearwater, Florida, 33765, United States

  • Sl0044 50659

    RECRUITING

    Marietta, Georgia, 30152, United States

  • Sl0044 50660

    RECRUITING

    New Orleans, Louisiana, 70112, United States

  • Sl0044 50662

    RECRUITING

    Glendale, Arizona, 85306, United States

  • Sl0044 50670

    RECRUITING

    Searcy, Arkansas, 72143, United States

  • Sl0044 50671

    RECRUITING

    Caguas, Puerto Rico

  • Sl0044 50673

    RECRUITING

    Fort Worth, Texas, 76109, United States

  • Sl0044 50677

    RECRUITING

    Scottsdale, Arizona, 85258, United States

  • Sl0044 50681

    RECRUITING

    Miami, Florida, 33172, United States

  • Sl0044 50682

    RECRUITING

    Kansas City, Missouri, 64151, United States

  • Sl0044 50683

    RECRUITING

    San Juan, Puerto Rico

  • Sl0044 50688

    RECRUITING

    Houston, Texas, 77054, United States

  • Sl0044 50693

    RECRUITING

    Murfreesboro, Tennessee, 37128, United States

  • Sl0044 50694

    RECRUITING

    Guadalajara, Mexico

  • Sl0044 50695

    RECRUITING

    Mexico City, Mexico

  • Sl0044 50696

    RECRUITING

    Houston, Texas, 77090, United States

  • Sl0044 50698

    RECRUITING

    Tampa, Florida, 33618, United States

  • Sl0044 50699

    RECRUITING

    Chicago, Illinois, 60616, United States

  • Sl0044 50713

    RECRUITING

    Gilbert, Arizona, 85297, United States

  • Sl0044 50717

    RECRUITING

    Willowbrook, Illinois, 60527, United States

  • Sl0044 50718

    RECRUITING

    Mansfield, Texas, 76063, United States

  • Sl0044 50719

    RECRUITING

    Aurora, Colorado, 80045, United States

  • Sl0044 50723

    RECRUITING

    Houston, Texas, 77090, United States

  • Sl0044 50725

    RECRUITING

    Menifee, California, 92586, United States

  • Sl0044 50730

    RECRUITING

    Rockville, Maryland, 20850, United States

  • Sl0044 50735

    RECRUITING

    Miami, Florida, 33155, United States

  • Sl0044 50737

    RECRUITING

    Beverly Hills, California, 90210, United States

  • Sl0044 50738

    RECRUITING

    Bellaire, Texas, 77401, United States

  • Sl0044 50747

    RECRUITING

    Miami, Florida, 33126, United States

  • Sl0044 50748

    RECRUITING

    New Albany, Indiana, 47150, United States

  • Sl0044 50751

    RECRUITING

    Coral Gables, Florida, 33134, United States

  • Sl0044 50755

    RECRUITING

    Los Alamitos, California, 90720, United States

  • Sl0044 50763

    RECRUITING

    Margate, Florida, 33063, United States

  • Sl0044 50766

    RECRUITING

    Hollywood, Florida, 33024, United States

  • Sl0044 50767

    RECRUITING

    San Juan, Puerto Rico

  • Sl0044 50771

    RECRUITING

    Québec, Canada

  • Sl0044 50773

    RECRUITING

    Grapevine, Texas, 76051, United States

  • Sl0044 50775

    RECRUITING

    Beverly Hills, California, 90211, United States

  • Sl0044 50781

    RECRUITING

    El Paso, Texas, 79902, United States

  • Sl0044 60002

    RECRUITING

    Capital Federal, Argentina

  • Sl0044 60003

    RECRUITING

    Quilmes, Argentina

  • Sl0044 60004

    RECRUITING

    C.a.b.a, Argentina

  • Sl0044 60008

    WITHDRAWN

    San Juan de Lurigancho, Peru

  • Sl0044 60009

    RECRUITING

    Surco, Peru

  • Sl0044 60011

    RECRUITING

    San Juan, Argentina

  • Sl0044 60014

    RECRUITING

    San Miguel de Tucumán, Argentina

  • Sl0044 60018

    RECRUITING

    Santiago, Chile

  • Sl0044 60024

    RECRUITING

    Córdoba, Argentina

  • Sl0044 60026

    WITHDRAWN

    Arequipa, Peru

  • Sl0044 60029

    RECRUITING

    Mendoza, Argentina

More trials for these conditions

Other studies related to the condition(s) this trial covers.